Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Meningococcal Conjugate Vaccine MCV4

Known as: MCV4, Meningococcal Conjugate Vaccine MCV-4, Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Diphtheria Toxoid Conjugated Vaccine 
A conjugate vaccine of meningococcal polysaccharide used for active immunization against invasive meningococcal disease caused by Neisseria… Expand
National Institutes of Health

Related topics

Related topics

1 relation
Vaccines, Conjugate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Text4Health: impact of text message reminder-recalls for pediatric and adolescent immunizations.
OBJECTIVES We conducted 2 studies to determine the impact of text message immunization reminder-recalls in an urban, low-income… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2012
2012
Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in 2- to 10-year-old Human Immunodeficiency Virus-infected Children
Background: Human immunodeficiency virus (HIV)-infected children are at increased risk of meningococcal infection and poor… Expand
Is this relevant?
2012
2012
Safety and immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic hematopoietic stem cell transplantation.
Given the high morbidity and mortality associated with meningococcal disease, in 2007 the Advisory Committee of Immunization… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
HPV vaccine decision making in pediatric primary care: a semi-structured interview study
BackgroundDespite national recommendations, as of 2009 human papillomavirus (HPV) vaccination rates were low with < 30% of… Expand
  • table 1
  • table 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.
BACKGROUND A quadrivalent meningococcal conjugate vaccine (MCV4) was licensed in the United States in 2005; no serogroup B… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescents
The persistence of human bactericidal activity (hSBA) responses in adolescents was assessed 22 months after vaccination with one… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age.
BACKGROUND Routine administration of quadrivalent meningococcal conjugate vaccine to adolescents and certain high risk groups is… Expand
Is this relevant?
2008
2008
Report from the Advisory Committee on Immunization Practices (ACIP): decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine…
  • MMWR. Morbidity and mortality weekly report
  • 2008
    • Corpus ID: 25777889
At its February 2008 meeting, the Advisory Committee on Immunization Practices (ACIP) decided not to recommend routine… Expand
Is this relevant?
Review
2007
Review
2007
Use of Meningococcal Vaccines in the United States
In January 2005, Food and Drug Administration licensed a new tetravalent (serogroups A, C, Y, W-135) meningococcal conjugate… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Prevention of Pertussis Among Adolescents: Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine
The purpose of this statement is to provide the rationale and recommendations for adolescent use of tetanus toxoid, reduced… Expand
  • figure 1
  • figure 2
  • table 1
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE